CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 255,957 shares, an increase of 1,547.0% from the November 30th total of 15,541 shares. Based on an average daily volume of 587,208 shares, the short-interest ratio is presently 0.4 days. Currently, 0.1% of the shares of the stock are sold short. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 587,208 shares, the short-interest ratio is presently 0.4 days.
CV Sciences Price Performance
Shares of CVSI stock opened at $0.06 on Thursday. CV Sciences has a 1-year low of $0.02 and a 1-year high of $0.10. The company has a quick ratio of 0.21, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The stock has a 50 day simple moving average of $0.03 and a 200-day simple moving average of $0.04.
About CV Sciences
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Featured Articles
- Five stocks we like better than CV Sciences
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
